US strikes down Trump's 10% tariffs — How should India proceed now?

The U.S. Court of International Trade struck down the Trump administration’s 10% global tariffs under Section 122, calling them "invalid" and "unauthorized by law." The ruling currently applies only to the plaintiffs, with other importers still subject to tariffs while the government appeals to the Federal Circuit and potentially the Supreme Court. The decision adds fresh uncertainty to U.S. trade policy and has prompted GTRI to advise India to reconsider Free Trade Agreement talks with Washington.

Analysis

The immediate market read-through is not “lower tariffs” but “higher policy volatility discount.” Repeated judicial setbacks make tariff policy look less like a durable negotiating tool and more like a sequence of reversible shocks, which is bearish for firms that built pricing, inventory, and capex plans around sticky protectionism. The biggest beneficiary is not necessarily the broad import basket; it is the set of companies with high China/Asia sourcing intensity and low pass-through ability, because each additional month of uncertainty forces them to hold more inventory and hedge more aggressively, depressing gross margin and working capital efficiency.

The second-order effect is on trade counterparties: if US concessions are legally unstable while foreign concessions are permanent, rational negotiators will stall rather than pre-pay for temporary relief. That raises the odds that supply chain re-routing accelerates away from the US toward ASEAN, Mexico, and the EU over the next 6-18 months, especially for discretionary retail, toys, home goods, and low-complexity industrial inputs. For domestic protected producers, this is actually negative over time: the tariff shield becomes less valuable if courts keep invalidating it, but companies may have already misallocated capex into capacity that was justified by transient policy.

On the legal path, the relevant catalyst is not the next headline ruling but whether relief expands nationwide or remains plaintiff-limited. If the appellate process preserves the status quo for months, the real economic impact is the drag from uncertainty rather than the tariff rate itself; that tends to favor volatility over direction in the near term. If a higher court narrows presidential tariff authority, expect a repricing of the entire “trade war premium” embedded in import-sensitive retailers and manufacturers, but also a partial rebound in EM exporters as order flows normalize.

The contrarian angle: the market may be underestimating how much this weakens the administration’s bargaining leverage, but also overestimating the permanence of the current MFN regime. A legal vacuum can just as easily invite a shift toward more targeted, easier-to-defend remedies under other statutes, which would be less visible but more durable. That argues for trading the uncertainty rather than making a binary call on tariffs: long beneficiaries of stable supply chains, short names whose margin story depends on policy protection.

Key Decisions for Investors

• Long XRT or SHLD-style importers? No. Prefer a long basket of import-sensitive retailers/brands with limited pricing power: long AMZN / COST / TGT on a 3-6 month horizon if tariff uncertainty persists, because they benefit from lower landed-cost risk and can gain share from smaller peers with weaker sourcing optionality.
• Short a basket of domestic protected manufacturers with tariff-dependent margin narratives over 6-12 months; pair that short against XLV or XLI to isolate policy beta. Risk/reward improves if appellate timing stretches, because capex assumptions become harder to justify.
• Buy downside protection on a small-cap retail importer ETF proxy or individual names with concentrated Asia sourcing for 2-4 months out; volatility is cheap relative to the probability of either a nationwide injunction or a policy workaround that resets pricing expectations abruptly.
• Relative value: long MXN/ASEAN export proxies vs short India trade-sensitive EMS/logistics names if the market starts pricing a shift in sourcing away from the US-centered trade framework; the next 1-2 quarters should reward alternative manufacturing hubs even without a full tariff rollback.